USPTO serial 77737137
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives containing galantamine for use in the manufacture of Tablets, Injections, Aerosols, Gels, Time-Released Products, therapeutic patches, prophylactic patches containing galantamine | ACTIVE | — |
| 005 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals containing galantamine; Drug delivery agents in the form of capsules that provide controlled release of galantamine together with other pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of galantamine together with other pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of galantamine together with other pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of organophosphate toxicity; Inhalers filled with galantamine; Pharmaceutical preparations containing galantamine acting on the central nervous system; Pharmaceutical preparations and substances containing galantamine for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system toxicity related diseases and disorders; Pharmaceutical preparations containing galantamine for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations containing galantamine for the treatment of inflammatory disorders; Pharmaceutical preparations containing galantamine for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of organophosphate toxicity; Pharmaceutical preparations for the treatment of organophosphate toxicity; Plant extracts containing galantamine for medical, veterinary and pharmaceutical purposes; Syringes sold filled with galantamine; Therapeutic pharmaceutical for the treatment of organophosphate toxicity | ACTIVE | — |
| 016 | Information leaflets concerning pharmaceuticals containing galantamine | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2012 | PC.D | PETITION TO DIRECTOR DISMISSED | — |
| Dec 13, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 13, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 6, 2012 | INCE | ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST | — |
| Oct 17, 2012 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 20, 2012 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| May 31, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 12, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 11, 2011 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jul 11, 2011 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 11, 2011 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 5, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 5, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 14, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 18, 2011 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jan 18, 2011 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 18, 2011 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 3, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 3, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 1, 2010 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 6, 2010 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 19, 2010 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Mar 16, 2010 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 19, 2010 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Oct 2, 2009 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 22, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 19, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 19, 2009 | ALIE | ASSIGNED TO LIE | — |
| Aug 13, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 13, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 13, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 13, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 13, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 12, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| May 18, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 18, 2009 | NWAP | NEW APPLICATION ENTERED | — |